- Home
- CLNN vs RACC Comparison
CLNN vs RACC Comparison
Compare CLNN & RACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNN | RACC |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | 79 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 102.8M |
| IPO Year | N/A | 2026 |
Fundamental Metrics
Financial Performance| Metric | CLNN | RACC |
|---|---|---|
| Price | $6.36 | $11.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $33.75 | N/A |
| AVG Volume (30 Days) | ★ 68.2K | 3.4K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $19,516.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.25 | $10.39 |
| 52 Week High | $13.50 | $12.38 |
Technical Indicators
Market Signals| Indicator | CLNN | RACC |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 71.67 |
| Support Level | $5.39 | $10.40 |
| Resistance Level | $6.63 | $12.38 |
| Average True Range (ATR) | 0.34 | 0.57 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 83.73 | 45.73 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About RACC Research Alliance Corporation III Class A Ordinary Shares
Research Alliance Corporation III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.